Monoclonal antibody treatments resume for those testing positive for COVID-19

CDR Health, a COVID-19 testing, vaccination, and monoclonal antibody therapy provider, says the sites will administer supplies of Sotrovimab first, followed by the recently approved Bebtelovimab. Both FDA-EUA authorized monoclonal antibody treatments have been shown to be effective against the Omicron variant.